View the 2018 Scientific Programme
Saturday 29 September 2018
Successful immune tolerance induction in the first case of neutralizing antibody mediated loss of efficacy of asfotase alfa treatment in hypophosphatasia.
Gabriel Á. Martos-Moreno (Madrid, Spain)
Adalbert Raimann (Vienna, Austria)
Steven Woods (Manchester, UK)
A recurrent 6-bp intronic deletion in NESP55 with reduced penetrance in pseudohypoparathyroidism type 1b.
Dong Li (Philadelphia, USA)
Maria Efthymia Katsa (Sparta, Greece)
Nursel Muratoglu Sahin (Ankara, Turkey)
Effect of Homocysteine-Lowering Therapy on Diabetic Nephropathy in Children and Adolescents with Type 1 Diabetes.
Nancy Elbarbary (Cairo, Egypt)
Persistent beneficial effects of metformin in children and adolescents with type 1 diabetes: Adelaide metformin randomized controlled trial follow up.
Alexia Peña (North Adelaide, Australia)
Pavlos Fanis (Nicosia, Cyprus)
Maria Consolata Miletta (New Haven, USA)
Sasha Howard (London, UK)
Irina Nikitina (Saint-Petersburg, Russian Federation)
National UK guidelines for the clinical assessment, diagnosis, treatment and follow-up of children and young people (CYP) under 19 years of age with phaeochromocytoma (PCC) and paraganglioma (PGL) - On behalf of the UK Paediatric Phaeochromocytoma and Paraganglioma Guideline Development Group (GDG).
Harshini Katugampola (London, UK)
The diagnostic yield of a targeted next generation sequencing panel in children with short stature of undefined aetiology.
Reena Perchard (Manchester, UK)
Methylation of the C19MC microrna locus in the placenta: A mechanism whereby maternal body size links to that of the child.
Abel Lopez-Bermejo (Girona, Spain)
Ewa Błaszczyk (Katowice, Poland)
Margaret Zacharin (Melbourne, Australia)
Diagnosis and management of pseudohypoparathyroidism and related disorders: First international consensus statement.
Susanne Thiele (Lübeck, Germany)
Increased levels of bone formation and resorption markers in patients with hypophosphatemic rickets.
Signe Sparre Beck-Nielsen (Kolding, Denmark)
Suet Ching Chen (Glasgow, UK)
Use of acid-suppressive medications during infancy and early childhood and its association with type 1 diabetes.
Sruthi Menon (Cleveland, USA)
Jens Otto Broby Madsen (Herlev, Denmark)
Barriers and sources of support for the performance of physical activity inpediatric type 1 diabetes.
Michal Cohen (Haifa, Israel)
Use of telemonitoring via a mobile device app reduces HbA1c in type 1 diabetic children and adolescents.
Philippe Klee (Geneva, Switzerland)
Konstantina Mouzaki (Thessaloniki, Greece)
Lixue Ouyang (Chengdu, China)
Gain in predicted adult height using the combination of an LHRH analogue and an aromatase inhibitor in early maturing girls with compromised growth for 2 yrs or until the age of 11 is maintained and further improved by aromatase inhibitor monotherapy. Results on final height of the “GAIL” study ISRCTN11469487.
Dimitrios T. Papadimitriou (Athens, Greece)
Alexander Siegfried Busch (Copenhagen, Denmark)
Flora Bacopoulou (Athens, Greece)
Yassmin Musthaffa (South Brisbane, Australia)
A novel germline DICER1 mutation in a girl with multinodular goiter and ovarian Sertoli-Leydig cell tumor.
Nikolaos Settas (Bethesda, USA)
Annemarie Verrijn Stuart (Utrecht, The Netherlands)
Bradley Miller (Minneapolis, USA)
Anu Beshamboo (Paris, France)
Juraj Stanik (Bratislava, Slovakia)
Violeta Iotova (Varna, Bulgaria)
Odysseas Androutsos (Athens, Greece)